Eduard Ling

Dr. Eduard Ling


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2018 in Cancers
Verified
Journal Article
Open access
PDF file
SLSergio Lamprecht
Sergio Lamprecht
ISIna SigalBatikoff
Ina SigalBatikoff
SSShraga Shany
Shraga Shany
NANaim Abu-Freha
Naim Abu-Freha
ELEduard Ling
Eduard Ling
AFAlexander Fich
Alexander Fich
It is well recognized that cancer cells subvert the phenotype of stromal naïve fibroblasts and instruct the neighboring cells to sustain their growth agenda. The mechanisms underpinning the switch of fibroblasts to cancer-associated fibroblasts (CAFs) are the focus of intense investigation. One of the most significant hallmarks of the biological identity of CAFs is that their tumor-promoting phenotype is stably maintained during in vitro and ex vivo propagation without the continual interaction with the adjacent cancer cells. In this review, we discuss robust evidence showing that the master cytokine Transforming Growth Factor-β1 (TGFβ-1) is a prime mover in reshaping, via epigenetic switches, the phenotype of stromal fibroblasts to a durable state. We also examine, in detail, the pervasive involvement of TGFβ-1 signaling from both cancer cells and CAFs in fostering cancer development, taking colorectal cancer (CRC) as a paradigm of human neoplasia. Finally, we review the stroma-centric anticancer therapeutic approach focused on CAFs—the most abundant cell population of the tumor microenvironment (TME)—as target cells.

23 September 2015 in Hematology Reports
Verified
Journal Article
Open access
GLGalina Ling
Galina Ling
VPVered Pinsk
Vered Pinsk
ITInbal Golan Tripto
Inbal Golan Tripto
ELEduard Ling
Eduard Ling
Congenital dyserythropoietic anemias (CDA) represent a heterogeneous group of disorders characterized by morphological abnormalities of erythroid precursor cells and various degrees of hemolysis. Iron overload is a result of continuous hemolysis and recurrent transfusions. It is treated with iron chelators, including deferasirox. We present here a case of acute liver failure in a 12 years old girl with CDA type I treated with deferasirox and discuss the approach to treatment.

30 May 2018 in Anticancer Research
Verified
Journal Article
Closed access
PDF file
GLGalina Ling
Galina Ling
SLSergio Lamprecht
Sergio Lamprecht
GSGeorge Shubinsky
George Shubinsky
LOLidia Osyntsov
Lidia Osyntsov
BYBaruch Yerushalmi
Baruch Yerushalmi
ELEduard Ling
Eduard Ling
Background/Aim: Familial adenomatous polyposis (FAP) was found to be completely reversed in a patient treated with mycophenolate mofetil (MMF) and tacrolimus following kidney transplantation. In this preliminary study, we assessed whether MMF and tacrolimus alone or in combination interfere with the cell cycle and proliferation in a human colonic adenocarcinoma cell line and in the colonic polyps of the patient with FAP. Materials and Methods: Human colonic adenocarcinoma HT-29 cells were treated with tacrolimus and MMF alone and in combination at different concentrations. Cell viability and proliferation were assessed using the MTT assay. Cell-cycle distribution was analyzed by flow cytometry. Expression of Ki-67, a marker of mitotic activity, was evaluated in the patient's colonic polyps before and under drug treatment. Results: MMF in combination with tacrolimus induced S-phase cell-cycle arrest and markedly inhibited HT-29 cell proliferation. Ki-67 expression in the patient's colonic polyps was significantly reduced following combined tacrolimus and MMF treatment. Conclusion: MMF and tacrolimus synergistically inhibited proliferation of a human colonic adenocarcinoma cell line and interfered with the expansion of colonic crypt proliferation in the polyp from a patient with FAP. The results confirm our clinical observation and indicate the possibility of novel approach to therapy of colorectal neoplasia.

20 June 2013 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
ELEduard Ling
Eduard Ling
DLDaniel Landau
Daniel Landau
HKHanna Krymko
Hanna Krymko

15 October 2020 in JCR: Journal of Clinical Rheumatology
Verified
Journal Article
Closed access
ELEduard Ling
Eduard Ling
GLGalina Ling
Galina Ling
YGYael Ben Baruch Golan
Yael Ben Baruch Golan
An abstract is unavailable. This article is available as a PDF only.

12 December 2016 in International Journal of Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
ELEduard Ling
Eduard Ling
GLGalina Ling
Galina Ling
VPVered Pinsk
Vered Pinsk